Jobs at Elasmogen
Biopharma developing ELN28, a dual-acting TNFα and JAK inhibitor conjugate for hidradenitis suppurativa patients
Company profile →0 jobs open
Elasmogen has no open positions listed right now.
Biopharma developing ELN28, a dual-acting TNFα and JAK inhibitor conjugate for hidradenitis suppurativa patients
Company profile →0 jobs open